Get started
Author

Myong Cheol Lim

Phase II study of durvalumab and tremelimumab with front-line neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer: primary analysis in the original cohort of KGOG3046/TRU-D
2023 · Junsik Park, Jung Bok Lee, et al. · Journal for ImmunoTherapy of Cancer · 25
PDF
Psychosocial barriers and facilitators for cascade genetic testing in hereditary breast and ovarian cancer: a scoping review
2024 · Agani Afaya, Sung-Won Kim, et al. · Familial Cancer · 19
Prognostic value of CA125 kinetics, half-life, and nadir in the treatment of epithelial ovarian cancer: a systematic review and meta-analysis
2023 · Ji Hyun Kim, Hyun-Woong Cho, et al. · International Journal of Gynecological Cancer · 17
Proteogenomic characterization of molecular and cellular targets for treatment-resistant subtypes in locally advanced cervical cancers
2025 · Do Young Hyeon, Dowoon Nam, et al. · Molecular Cancer · 16
Efficacy of immune-checkpoint inhibitors combined with cytotoxic chemotherapy in advanced or recurrent endometrial cancer: A systematic review and meta-analysis
2024 · Ji Hyun Kim, Kyung Hee Han, et al. · Gynecologic Oncology · 14
PDF
Comparison of survival outcomes between olaparib and niraparib maintenance therapy in BRCA-mutated, newly diagnosed advanced ovarian cancer
2023 · Ji Hyun Kim, Se Ik Kim, et al. · Gynecologic Oncology · 11
Initial results from a first-in-human phase 1 study of LY4170156, an ADC targeting folate receptor alpha (FRα), in advanced ovarian cancer and other solid tumors.
2025 · Isabelle Laure Ray-Coquard, David M. O'Malley, et al. · Journal of Clinical Oncology · 7
PDF
Surgery for Recurrent Epithelial Ovarian Cancer
2023 · Christina Fotopoulou, Ane Gerda Eriksson, et al. · Current Oncology Reports · 6
PDF
Surgical outcomes of rectosigmoid colon resection versus rectosigmoid wall stripping for superficial rectal wall tumors at cytoreductions for advanced ovarian cancer
2025 · Jaekyung Bae, Dong Woon Lee, et al. · International Journal of Gynecological Cancer · 4
OPERA: a phase II trial of oregovomab plus non-platinum chemotherapy in PARP inhibitor/platinum-resistant ovarian cancer
2024 · Junsik Park, Hyun Woong Cho, et al. · Future Oncology · 4
PDF
Utility of CA125 KELIM in predicting benefit from hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer: pooled analysis of KGOG3042 and KOV-HIPEC-01
2025 · Hyun-Woong Cho, Suk-Joon Chang, et al. · International Journal of Gynecological Cancer · 3
A randomized phase II study of secondary cytoreductive surgery in patients with relapsed ovarian cancer who have progressed on a PARP inhibitor as first-line maintenance therapy: the SOCCER-P study (KGOG 3067/JGOG 3036/APGOT-OV11)
2024 · Hyun-Woong Cho, Hee-Seung Kim, et al. · International Journal of Gynecological Cancer · 3
Survival impact and prognostic factors of secondary cytoreduction in platinum-sensitive recurrent ovarian cancer: a systematic review and trial-level meta-analysis
2025 · Ji Hyun Kim, Myong Cheol Lim, et al. · International Journal of Gynecological Cancer · 2
Prognostic value and adjuvant treatment outcomes for the use of the JGOG prognostic model in early-stage intermediate-risk cervical cancer: a Korean Gynecologic Oncology Group study (KGOG 1028)
2026 · Uisuk Kim, Jaekyung Bae, et al. · Journal of Gynecologic Oncology · 1
PDF
Correction: Proteogenomic characterization of molecular and cellular targets for treatment‑resistant subtypes in locally advanced cervical cancers
2025 · Do Young Hyeon, Dowoon Nam, et al. · Molecular Cancer · 1
PDF
Feasibility of ChatGPT-4o in management of gynecologic oncologic patients in the emergency department.
2025 · Junhwan Kim, Uisuk Kim, et al. · Journal of Clinical Oncology · 1
Docetaxel/Cisplatin Chemotherapy Followed by Pelvic Radiation Therapy in Patients With High-risk Endometrial Cancer After Staging Surgery: A Phase 2 Study
2024 · Ok-Ju Kang, Yoon-Jung Cho, et al. · International Journal of Radiation Oncology*Biology*Physics · 1
Clinical Significance of BRIP1 Pathogenic Germline Variant
2026 · Hee-Won Han, Min-Chae Kang, et al. · Laboratory Medicine Online
PDF
Hybrid surgical approach for advanced ovarian cancer: hybrid approach for robotic and minimal open abdominal cytoreduction technique
2026 · Jaekyung Bae, Uisuk Kim, et al. · Obstetrics & Gynecology Science
PDF
Hybrid surgical approach for advanced ovarian cancer: hybrid approach for robotic and minimal open abdominal cytoreduction technique
2026 · Jaekyung Bae, Uisuk Kim, et al. · Obstetrics & Gynecology Science
Impact of tremelimumab dosing and sequence on tumor immune microenvironment and efficacy of neoadjuvant chemotherapy in advanced ovarian cancer: Insights from the TRU-D/KGOG-3046 study
2025 · Junsik Park, Je-Gun Joung, et al. · Gynecologic Oncology
Utility of the CA125 KELIM in for predicting the benefit of from HIPEC in patients with advanced ovarian cancer: pooled analysis of individual data from KGOG3042 and KOV-HIPEC01
2025 · Hyun-Woong Cho, Suk-Joon Chang, et al. · Gynecologic Oncology
Correction: Proteogenomic characterization of molecular and cellular targets for treatment‑resistant subtypes in locally advanced cervical cancers
2025 · Do Young Hyeon, Dowoon Nam, et al. · Molecular Cancer
PDF
Utility of the CA125 KELIM in for Predicting the Benefit of from HIPECin Patients with Advanced Ovarian Cancer: Pooled Analysis of Individual Data from KGOG3042 and KOV-HIPEC-01
2025 · Hyun-Woong Cho, Suk-Joon Chang, et al. · SSRN Electronic Journal
EV363/#815 Clinical outcome and pattern of care for isolated/incidental serous tubal intraepithelial carcinoma (STIC): multicenter retrospective cohort study
2024 · Bo Ra Kim, Se Ik Kim, et al. · International Journal of Gynecological Cancer
Works count: 40
Citation count: 135
H-index: 7
I10-index: 6
Year
Topic
Type